Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation|Triple-Negative Breast Cancer
Interventions: DRUG: Veliparib|DRUG: Cisplatin|DRUG: Vinorelbine
Sponsor: University of Washington
Collaborators: AbbVie